Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A profile of childhood neuropathies at a university hospital in Oman.
Regulatory dendritic cell therapy: From rodents to clinical application.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Neurological involvement in primary sjögren syndrome: a focus on central nervous system.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease.
MS nurses join project to prove the value of specialist role.
Vagomimetic effects of fingolimod: physiology and clinical implications.
Month of birth is not a definite risk factor for multiple sclerosis.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Analysis of macular OCT images using deformable registration.
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Oligodendrocyte Development and Plasticity.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Extra-hippocampal subcortical limbic involvement predicts episodic recall performance in multiple sclerosis.
Impaired social cognition in multiple sclerosis.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Loss of branched o-mannosyl glycans in astrocytes accelerates remyelination.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.

Pages